These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thalidomide in myelofibrosis with myeloid metaplasia: a pooled-analysis of individual patient data from five studies. Barosi G, Elliott M, Canepa L, Ballerini F, Piccaluga PP, Visani G, Marchetti M, Pozzato G, Zorat F, Tefferi A. Leuk Lymphoma; 2002 Dec; 43(12):2301-7. PubMed ID: 12613516 [Abstract] [Full Text] [Related]
3. Thalidomide treatment in myelofibrosis with myeloid metaplasia. Elliott MA, Mesa RA, Li CY, Hook CC, Ansell SM, Levitt RM, Geyer SM, Tefferi A. Br J Haematol; 2002 May; 117(2):288-96. PubMed ID: 11972510 [Abstract] [Full Text] [Related]
4. Thalidomide therapy for myelofibrosis with myeloid metaplasia. Thomas DA, Giles FJ, Albitar M, Cortes JE, Verstovsek S, Faderl S, O'Brien SM, Garcia-Manero G, Keating MJ, Pierce S, Zeldis J, Kantarjian HM. Cancer; 2006 May 01; 106(9):1974-84. PubMed ID: 16583431 [Abstract] [Full Text] [Related]
5. Thalidomide in agnogenic and secondary myelofibrosis. Canepa L, Ballerini F, Varaldo R, Quintino S, Reni L, Clavio M, Miglino M, Pierri I, Gobbi M. Br J Haematol; 2001 Nov 01; 115(2):313-5. PubMed ID: 11703326 [Abstract] [Full Text] [Related]
6. Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial. Marchetti M, Barosi G, Balestri F, Viarengo G, Gentili S, Barulli S, Demory JL, Ilariucci F, Volpe A, Bordessoule D, Grossi A, Le Bousse-Kerdiles MC, Caenazzo A, Pecci A, Falcone A, Broccia G, Bendotti C, Bauduer F, Buccisano F, Dupriez B. J Clin Oncol; 2004 Feb 01; 22(3):424-31. PubMed ID: 14752066 [Abstract] [Full Text] [Related]
8. Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study. Piccaluga PP, Visani G, Pileri SA, Ascani S, Grafone T, Isidori A, Malagola M, Finelli C, Martinelli G, Ricci P, Baccarani M, Tura S. Leukemia; 2002 Sep 01; 16(9):1609-14. PubMed ID: 12200671 [Abstract] [Full Text] [Related]
10. Thalidomide for the treatment of idiopathic myelofibrosis. Strupp C, Germing U, Scherer A, Kündgen A, Mödder U, Gattermann N, Haas R. Eur J Haematol; 2004 Jan 01; 72(1):52-7. PubMed ID: 14962263 [Abstract] [Full Text] [Related]
13. A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia. Mesa RA, Steensma DP, Pardanani A, Li CY, Elliott M, Kaufmann SH, Wiseman G, Gray LA, Schroeder G, Reeder T, Zeldis JB, Tefferi A. Blood; 2003 Apr 01; 101(7):2534-41. PubMed ID: 12517815 [Abstract] [Full Text] [Related]